Skip to content

A randomized controlled clinical trial to evaluate the efficacy and safety of azithromycin in periodontal bone defect repair

Azithromycin promote periodontal tissue regeneration through modulating inflammatory microenvironment via removing senescent cells

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035453
Enrollment
Unknown
Registered
2020-08-11
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodontal disease

Interventions

control group: amoxicillin and metronidazole

Sponsors

School and hospital of Stomatology, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Male or female, aged 18-65 years, in good health; willing and able to sign informed consent; clinically diagnosed as periodontitis, the study tooth has periodontal vertical bone defect, with baseline PD >=7mm. After operative debridement, it is a vertical bone defect located adjacent to the tooth, and the depth of the vertical bone defect is >=4mm, there is at least one bone wall, with keratinized gingiva of >=2mm width, and X-ray shows that the base of bone defect is at least 3 mm in the crown of the root apex; the teeth will be cleaned and scraped within 2 months before joining the group; the tooth mobility is less than or equal to I degree; and there is no root furcation disease.

Exclusion criteria

Exclusion criteria: Patients with systemic disease history; patients allergic to azithromycin, amoxicillin or metronidazole; study tooth with periodontal surgery history; patients with acute infection at the surgical site; patients with smoking; patients who are participating in other clinical trials; subjects who object to the use of pig derived materials due to religious reasons; subjects with poor predicted compliance or with other factors that not suitable for this trial.

Design outcomes

Primary

MeasureTime frame
clinical attachment level (CAL);probing depth (PD);Bone filling percentage;

Secondary

MeasureTime frame
Gingival retraction;

Countries

China

Contacts

Public ContactXiangzhen Yan

School and hospital of Stomatology, Tongji University

xiangzhenyan03@163.com+86 17717913175

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026